Inari Medical to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum

Rhea-AI Summary

Inari Medical (NASDAQ: NARI) announced its participation in the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020. The company specializes in developing innovative medical devices aimed at treating venous diseases, focusing on its mechanical thrombectomy systems, ClotTriever and FlowTriever, which are FDA-cleared for deep vein thrombosis and pulmonary embolism, respectively. Inari's mission is to transform patient care by providing effective treatments that eliminate the need for traditional thrombolytic drugs.

IRVINE, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) announced today that its management team will participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020.

About Inari Medical, Inc.
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.

Investor Contact:
Westwicke Partners
Caroline Corner
Phone +1-415-202-5678
caroline.corner@westwicke.com

FAQ

When is Inari Medical participating in the Canaccord Genuity Virtual MedTech & Diagnostics Forum?

Inari Medical will participate in the forum on November 19, 2020.

What medical devices does Inari Medical develop?

Inari Medical develops catheter-based mechanical thrombectomy devices for treating venous diseases, specifically deep vein thrombosis and pulmonary embolism.

What is the significance of the ClotTriever and FlowTriever systems?

The ClotTriever and FlowTriever systems are FDA-cleared devices designed to remove large clots from veins, eliminating the need for thrombolytic drugs.

What types of venous diseases does Inari Medical focus on?

Inari Medical focuses on treating deep vein thrombosis and pulmonary embolism.

What is the stock symbol for Inari Medical?

The stock symbol for Inari Medical is NARI.